Expertise in
32
conditions

Dr. Jonathan I. Silverberg

Dermatology
Gw Dermatology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW, 
Washington, DC 
Accepting New Patients
17 Years of Experience
Referral required
Before you request
Expertise in
32
conditions
Gw Dermatology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW, 
Washington, DC 

Overview

Jonathan Silverberg is a Dermatologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years.

Dr. Silverberg is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Atopic Dermatitis, Stasis Dermatitis and Ulcers, Contact Dermatitis, and Vitiligo.

He is actively involved in clinical research, co-authoring 800 peer reviewed articles and participating in 5 clinical trials. Dr. Silverberg is currently accepting new patients.

Graduate Year

2009

Specialties

Dermatology

Licenses

Dermatology in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Gw Dermatology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW, Washington, DC 20037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2026
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 4 Less Clinical Trials

799 Total Publications

Correction: Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin).
Correction: Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin).
Journal: Dermatology and therapy
Published: August 28, 2026
Similar Doctors
Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required
Before you request

Valerie Callender M. D. PC

12200 Annapolis Rd Ste 315, 
Glenn Dale, MD 
 (14.0 miles away)
301-249-0970
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Valerie Callender is a Dermatologist practicing medicine in Glenn Dale, Maryland. Dr. Callender is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Acne, Melasma, Autosomal Recessive Hypotrichosis, and Contact Dermatitis. Dr. Callender is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

Hu Faculty Practice Plan-Dermatology

2041 Georgia Ave NW Ste 4300, 
Washington, DC 
 (0.8 miles away)
202-865-6725
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ginette Okoye is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Okoye is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Boils, Hidradenitis Suppurativa, Mycosis Fungoides, and Vitiligo. Dr. Okoye is currently accepting new patients.

Expertise in
15
conditions
Dr. Joseph A. Zahn
Dermatology
Expertise in
15
conditions
Dr. Joseph A. Zahn
Dermatology
Referral may be required
Before you request

GW The Medical Faculty Associate

2150 Pennsylvania Ave NW, 
Washington, DC 
 (0.1 miles away)
202-741-2600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Zahn is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Zahn is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Squamous Cell Skin Carcinoma, Atopic Dermatitis, and Bowen's Disease. Dr. Zahn is currently accepting new patients.

Frequently Asked Questions about Dr. Jonathan I. Silverberg

How do I make an appointment with Dr. Jonathan I. Silverberg?

You can book an appointment with Dr. Jonathan I. Silverberg by calling their office at 202-741-2600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jonathan I. Silverberg a top-rated expert for Atopic Dermatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonathan I. Silverberg is classified as an Elite expert for Atopic Dermatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jonathan I. Silverberg specialize in?

While Dr. Jonathan I. Silverberg is a Dermatology, they have specific expertise in Atopic Dermatitis, Stasis Dermatitis and Ulcers, and Contact Dermatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Jonathan I. Silverberg participate in research or clinical trials?

Yes. Dr. Jonathan I. Silverberg has published 799 articles and abstracts on conditions like Atopic Dermatitis. You can view a list of Dr. Jonathan I. Silverberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jonathan I. Silverberg accept my insurance?

Dr. Jonathan I. Silverberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-741-2600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silverberg's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 18 Advanced Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile